Currently out of the existing stock ratings of Catherine Schulte, 65 are a HOLD (18.01%), 296 are a BUY (81.99%).

Catherine Schulte

Work Performance Price Targets & Ratings Chart

Analyst Catherine Schulte, currently employed at BAIRD, carries an average stock price target met ratio of 66.33% that have a potential upside of 19.91% achieved within 261 days.

Catherine Schulte’s has documented 716 price targets and ratings displayed on 14 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on TECH, Bio-Techne Corp at 26-Jun-2026.

Wall Street Analyst Catherine Schulte

Analyst best performing recommendations are on MRVI (MARAVAI LIFESCIENCES HOLDINGS ).
The best stock recommendation documented was for CSTL (CASTLE BIOSCIENCES) at 8/19/2019. The price target of $27 was fulfilled within 11 days with a profit of $7.5 (38.46%) receiving and performance score of 34.97.

Average potential price target upside

of $59.78 (13.52%) on TMO (THERMO FISHER SCIENTIFIC).
of $51.22 (4.19%) on MTD (METTLER-TOLEDO INTERNATIONAL).
of $36.78 (17.62%) on DHR (DANAHER).

A Agilent Technologies CSTL Castle Biosciences ILMN Illumina NSTG NanoString Technologies NTRA Natera TWST Twist Bioscience Corp TMO Thermo Fisher Scientific WAT Waters EXAS EXACT Sciences MRVI Maravai Lifesciences Holdings OXFD Oxford Immunotec Global PLC TECH Bio-Techne Corp AA Alcoa Corp RVTY Revvity

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Kallum Titchmarsh (MORGAN STANLEY)